MDS-specific comorbidity index is useful to identify myelodysplastic patients who can have better outcome with 5-azacitidine.
Massimo
M
Breccia
Adriano
A
Salaroli
Giuseppina
G
Loglisci
Paola
P
Finsinger
Alessandra
A
Serrao
Giuliana
G
Alimena
D005260:Female; D006801:Humans; D008297:Male; D009190:Myelodysplastic Syndromes / Q000453:epidemiology*